In pancreatic cancer, SIRT6 facilitates cancer cell migration by promoting Ca2+ responses 16, while Kugel et al. 17 showed that SIRT6 loss contributes to metastasis and progression of pancreatic ductal adenocarcinoma via modulation of Lin28b. Here, SIRT6 is linked to pancreatic ductal adenocarcinoma.